Kenya Airways (KQ)
![KQ has been on a loss-making streak for the past nine years, with accumulated losses totaling Ksh144.64 billion. [Photo/ Lifestyle Afrique]](https://businesstoday.co.ke/wp-content/uploads/2022/03/images-30.jpeg)
KQ Eyes New Leasing Deal With Plane Owners
National carrier Kenya Airways (KQ) is seeking to have an amended lease deal with 12 plane owners in a bid to cut costs....
BT Reporter
KQ To Spend Ksh13 Billion Buying Flying Taxis
National carrier Kenya Airways(KQ) is set to buy 40 flying taxis from two Brazilian firms in a diversification move through its new subsidiary...
BT Reporter
KQ’s Suspension At The Bourse Extended For One More Year
The suspension from trading of Kenya Airways (KQ) shares at the Nairobi Stock Exchange (NSE) has been extended for 12 more months. In...
FRANCIS MULI
KQ Partners With Strathmore University To Support Innovative Business Solutions
National carrier Kenya Airways (KQ) and iBizAfrica Incubation Centre Strathmore University have partnered for the KQ’s Fahari Innovation Challenge to create opportunities for...
FRANCIS MUTINDA
KQ Leases Two Aircraft To Congo Airways, Inks Codesharing Deal
National carrier Kenya Airways PLC (KQ), has signed an aircraft lease agreement and begun operating a cargo codeshare partnership with Congo Airways. The...
BT Correspondent
KQ Missing as UN Names 14 Airlines to Ferry Covid-19 Vaccines
KQ was left out of the list despite it launching a modern pharma cargo facility at the Jomo Kenyatta International Airport (JKIA) last...
JUDITH NDUNDE
Kenya Airways Makes History Repurposing a Boeing 787 Into a ‘Phreighter’
The joint effort is a worldwide breakthrough as it is the first-ever cargo repurpose of this type to be performed on the Boeing...
JUDITH NDUNDE
KQ Aligns Flight Schedule With JKIA Express Rail Service as Prices Slashed
are from the Nairobi Central Station to JKIA has also been halved, from Ksh500 to Ksh250.
MARTIN SIELE
KQ Eyes Vaccine Distribution With New Pharma Facility
The pharma facility was launched as the world shifts focus to the safe and efficient global distribution of a Covid-19 vaccine in 2021.
MARTIN SIELE
